$ARCT

Arcturus Therapeutics Holdings Inc

  • NASDAQ
  • Health Technology
  • Pharmaceuticals: Major
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$18.34 โ–ผ-3.175%

Last Close

VOLUME

715,529

DAY RANGE

18.02 - 19.59

52 WEEK

11.7 - 65

Join Discuss about ARCT with like-minded investors

profile
@dros #droscrew
recently

Increasing unusual call volume: $VSCO $ARCT $RSI $BMO $KHC Increasing unusual put volume: $VSCO $ARCT $SID $RSI $BKSY $TXMD $KHC $PCG $KIRK $CRM

56 Replies 6 ๐Ÿ‘ 14 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

Upgrades 5/11: $ARCT $ARWR $AZEK $CELH $CRON $DINO $EA $EGHT $FTNT $GO $HL $NOVT $PLNT $PTON $ROAD $RXT $TCBK $TREX . Downgrades 5/11: $ALR $ARRY $AVYA $BHVN $CS $CVNA $DBD $DMS $GLW $HYFM $INO $JNCE $KERN $KPLT $LDI $ONTF $PEGA $PTON $RKT $U $UPST $VFF

145 Replies 14 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@cmoody954 #marketassasins
recently

ARCT is looking good. at 47.50 now

144 Replies 11 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

**1) ARCT** 2021 has not been kind to ARCT. As this is now near the levels of the beginning of the year after falling back on 12/28/20. Recent momentum and liquidity creeping in is indicating a possible run into 2022. Watch for the break over $47 for an opportunity to swing for calls to the $54 level which served as 12/29/20 gap down starting point. This is a small resistance as a break over $54 PT should be re adjusted to PT 1: $57, PT 2: $60, PT 3: $63. January contracts last available strike are the $55 with heavy open interest, contracts will be costly but present a risk vs reward of 1/3

85 Replies 11 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

400 $ARCT MAR2022 $80 Cs trade 4.15

73 Replies 6 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

400 $ARCT MAR2022 $80 Cs trade 4.15

47 Replies 12 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@CarlosH-carvan #ivtrades
recently

Cathie Wood's ARK Invest Posts Fund Purchases For Monday, Nov. 1, 2021: NTLA, BEAM, PATH, KTOS, VLD, NIU, BLDE, MKFG, ZM, GENI, EXAS, CDNA, ALLO, VERV, ARCT, ADPT, TWLO, HOOD, TOST

145 Replies 7 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@HeyShoe #droscrew
recently

$AFRM + $TGT Sezzle P-Ships $ELAN + Starboard $HUN + Starboard $ARCT, $MRTX + $MRK targets $MRVL + Guidance $M + Jana calls E-Commerce spin

87 Replies 11 ๐Ÿ‘ 6 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

200 $ARCT MAR2022 $75 Cs trade 9.7

100 Replies 9 ๐Ÿ‘ 15 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

200 $ARCT MAR2022 $75 Cs trade 9.7

90 Replies 15 ๐Ÿ‘ 9 ๐Ÿ”ฅ

AN
@andres168 #StockTraders.NET
recently

$arct non stop

127 Replies 14 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@Benlax #droscrew
recently

$ARKG shows the reflexivity... $6.9B AUM (< $500M at year end) with $3B of flows THIS QUARTER. It holds 5 stocks < $500M cap (a 0.25% weight in $PSTI is ~10% of the company and ~20% of $ARCT. YTD returns vs how much they own of each (only 5 stocks with negative returns).

113 Replies 14 ๐Ÿ‘ 11 ๐Ÿ”ฅ

profile
@Benlax #droscrew
recently

The most interesting buys disclosed by hedge funds in the last 5 days: $FSR tweeted already $SKLZ $NET $APPN $TRIP $MSTR $CDLX $ARCT $ATRA $IRWD $CHRS $GKOS $ZIOP $OXFD $MGLN Tweeted. $NVUS

111 Replies 12 ๐Ÿ‘ 6 ๐Ÿ”ฅ

profile
@FUZZJP #ivtrades
recently

BTO ARCT 65C 1/15/21 @3

118 Replies 15 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

+Initiations 1/7: $ACCD $AIRC $ARAY $ARCT $AWK $BDTX $CHTR $CVLB $DADA $EVH $INCY $INOV $KNOP $MGTA $NOG $NTST $ORTX $TDOC $TLMD $VEEV . -Initiations 1/7: $FMCC

49 Replies 8 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@FUZZJP #ivtrades
recently

$ARCT and $FLGT were on my scanner last week and I didn't think that the action was compelling enough lol

128 Replies 13 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@ashy2classy #droscrew
recently

Business Insider: Arcturus Therapeutics plummets 53% after analyst downgrades following COVID-19 vaccine trial updates (ARCT)

111 Replies 11 ๐Ÿ‘ 14 ๐Ÿ”ฅ

profile
@Navneet #droscrew
recently

whats $arct why it got dumped

92 Replies 10 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@Navneet #droscrew
recently

im 5 says $arct

117 Replies 10 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@Navneet #droscrew
recently

have a look on $arct

50 Replies 13 ๐Ÿ‘ 15 ๐Ÿ”ฅ

profile
@DaveDixon #CoreTrader
recently

US Market US closed lower yesterday, amid concerns over economic recovery and as hopes for additional stimulus faded. Arcturus Therapeutics Holdings plunged 54.2%, as the company provided a disappointing update on its Covid-19 vaccine candidate, ARCT-021. Target lost 0.8%, after the company sold its Dermstore operation to THG Holdings for a cash consideration of $350.0 million. On the flipside, Snap jumped 6.2%, after a top broker raised its target price on the stock to $70.0 per share from $47.0 per share. Continental Resources advanced 1.7%, after a top broker upgraded its rating on the stock to โ€˜Overweightโ€™ from โ€˜Sector Weightโ€™. Bausch Health added 0.3%, after the drugmaker announced that it would pay down another $275.0 million in debt on 31 December 2020. Boeing rose 0.1%, as the airline operator resumed passenger flights in the US after a two-year halt. The S&P 500 slipped 0.2%, to settle at 3,727.0. The DJIA fell 0.2%, to settle at 30,335.7, while the NASDAQ shed 0.4%, to close at 12,850.2. .

52 Replies 12 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@Pyrognosis #droscrew
recently

Stocktwits all buying ARCT now

121 Replies 15 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@Pyrognosis #droscrew
recently

like $ARCT lol

147 Replies 8 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@Pyrognosis #droscrew
recently

$ARCT wow, some real bag holders there

110 Replies 6 ๐Ÿ‘ 7 ๐Ÿ”ฅ

JC
@JCrow #StockTraders.NET
recently

stopped out $ARCT

111 Replies 6 ๐Ÿ‘ 11 ๐Ÿ”ฅ

JC
@JCrow #StockTraders.NET
recently

Long $ARCT - $113

102 Replies 6 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

846 $ARCT 18DEC20 $80 Cs trade 5.00

124 Replies 11 ๐Ÿ‘ 6 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

846 $ARCT 18DEC20 $80 Cs trade 5.00

81 Replies 12 ๐Ÿ‘ 14 ๐Ÿ”ฅ

profile
@dros #droscrew
recently

$ARCT exploding

69 Replies 14 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@Neptune5045 #StockTraders.NET
recently

$ARCT as well

108 Replies 7 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@PradeepB #droscrew
recently

sold arct for profits

96 Replies 8 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@viking #StockTraders.NET
recently

covered ARCT for +1 but terrible trade

44 Replies 12 ๐Ÿ‘ 11 ๐Ÿ”ฅ

profile
@viking #StockTraders.NET
recently

SS ARCT 53.74 will add

88 Replies 12 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@MT #StockTraders.NET
recently

added short to $ARCT position from Monday.

46 Replies 6 ๐Ÿ‘ 14 ๐Ÿ”ฅ

profile
@MT #StockTraders.NET
recently

added short $ARCT

147 Replies 12 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@MT #StockTraders.NET
recently

started short $ARCT small - target under 45

94 Replies 10 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@MT #StockTraders.NET
recently

done with $ARCT - great trade

137 Replies 7 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@MT #StockTraders.NET
recently

1/2 ARCT sold so far

144 Replies 15 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@MT #StockTraders.NET
recently

added $ARCT long

71 Replies 15 ๐Ÿ‘ 12 ๐Ÿ”ฅ

NM
@Nmccorry #StockTraders.NET
recently

What is the target for $ARCT?

127 Replies 11 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@MT #StockTraders.NET
recently

Long some ARCT

76 Replies 6 ๐Ÿ‘ 8 ๐Ÿ”ฅ

GO
@GOUAGHOU #StockTraders.NET
recently

Thank you guys for all the trades you shared. Thank you MT for the $ARCT trade. As I am going through the trades, I was wondering what kind of play was ARCT?

75 Replies 7 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@MT #StockTraders.NET
recently

we played ARCT , BIDU, BLNK, INO NKLA

109 Replies 12 ๐Ÿ‘ 7 ๐Ÿ”ฅ

Key Metrics

Market Cap

483.47 M

Beta

0

Avg. Volume

861.02 K

Shares Outstanding

26.42 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-08

Next Dividend Date

Company Information

Founded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. is a clinical-stage mRNA medicines and vaccines company with enabling technologies: (i) LUNARยฎ lipid-mediated delivery, (ii) STARRโ„ข mRNA Technology and (iii) mRNA drug substance along with drug product manufacturing expertise. Arcturus' diverse pipeline of RNA therapeutic and vaccine candidates includes mRNA vaccine programs for SARS-CoV-2 (COVID-19) and Influenza, and other programs to potentially treat Ornithine Transcarbamylase (OTC) Deficiency, and Cystic Fibrosis along with partnered programs including Glycogen Storage Disease Type 3, Hepatitis B Virus, and non-alcoholic steatohepatitis (NASH). Arcturus' versatile RNA therapeutics platforms can be applied toward multiple types of nucleic acid medicines including messenger RNA, small interfering RNA, replicon RNA, antisense RNA, microRNA, DNA, and gene editing therapeutics. Arcturus' technologies are covered by its extensive patent portfolio (209 patents and patent applications, issued in the U.S., Europe, Japan, China and other countries). Arcturus' commitment to the development of novel RNA therapeutics has led to collaborations with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, Ultragenyx Pharmaceutical, Inc., Takeda Pharmaceutical Company Limited, CureVac AG, Synthetic Genomics Inc., Duke-NUS Medical School, and the Cystic Fibrosis Foundation.

Website:

HQ: ,

Related News